Asklepios Kliniken
Asklepios Kliniken: Solid performance in 2022
EQS-News: Asklepios Kliniken
/ Key word(s): Annual Report
Asklepios Group: Solid performance in 2022 Hamburg, 28 April 2023. 2022 was a challenging financial year for Asklepios Kliniken GmbH & Co. KGaA that was dominated by global political and economic developments. The Asklepios Group’s healthcare facilities treated around 3.6 million patients in the 2022 financial year, a slight increase on the previous year (2021: 3.5 million). The Asklepios Group generated revenue of EUR 5.3 billion in the 2022 financial year (previous year: EUR 5.1 billion). Consolidated net operating income (EAT) amounted to EUR 131.9 million (2021: 106.3 million). Capital expenditure totalled EUR 314.0 million in the 2022 financial year (2021: EUR 332.6 million), while the internal financing ratio amounted to 69.5% (2021: 72.8%). The Asklepios Group enjoyed a stable financial position at the end of the 2022 financial year. The Group’s net debt amounted to EUR 1,376.8 million as at 31 December 2022 (31 December 2021: EUR 1,364.8 million), while cash and cash equivalents amounted to EUR 634.6 million (31 December 2021: EUR 647.2 million). The ratio of net debt to EBITDA for the past 12 months was 3.5x (31 December 2021: 3.6x). Asklepios will respond flexibly to the expected regulatory requirements in order to mitigate the potential effects on its business activity. Thanks to strategic investments in digitalisation and the shift towards outpatient care, as well as internally financed capital expenditure on its healthcare facilities amounting to EUR 218.3 million, Asklepios has created a sound basis for weathering the challenges well in economic terms. Overall, Asklepios anticipates stable revenue growth and largely positive economic development in 2023.
IR contact PR contact
Visit Asklepios online, on Facebook or on YouTube: gesundleben.asklepios.com
28.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. |